A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial.

A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial.

Item
http://www.wikidata.org/entity/Q36810081
Disease Type- and Status-Specific Alteration of CSF Metabolome Coordinated with Clinical Parameters in Inflammatory Demyelinating Diseases of CNSNatural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapyNotes on the epidemiology of multiple sclerosis, with special reference to dietary habits.Influence of Diet in Multiple Sclerosis: A Systematic Review.Dietary Interventions in Multiple Sclerosis: Development and Pilot-Testing of an Evidence Based Patient Education Program.Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot studyProfile of Circulatory Metabolites in a Relapsing-remitting Animal Model of Multiple Sclerosis using Global Metabolomics.Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review.The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.The role of diet in multiple sclerosis: A review.The influence of sodium on pathophysiology of multiple sclerosis.Improvement of oxidative and metabolic parameters by cellfood administration in patients affected by neurodegenerative diseases on chelation treatment.Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis.Combination treatment of docosahexaenoic acid (DHA) and all-trans-retinoic acid (ATRA) inhibit IL-17 and RORγt gene expression in PBMCs of patients with relapsing-remitting multiple sclerosis.A review on potential roles of vitamins in incidence, progression, and improvement of multiple sclerosis.Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring.
P2860

A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial.

Item
http://www.wikidata.org/entity/Q36810081
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A novel oral nutraceutical for ...... oof-of-concept clinical trial.
@ast
A novel oral nutraceutical for ...... oof-of-concept clinical trial.
@en
type
label
A novel oral nutraceutical for ...... oof-of-concept clinical trial.
@ast
A novel oral nutraceutical for ...... oof-of-concept clinical trial.
@en
prefLabel
A novel oral nutraceutical for ...... oof-of-concept clinical trial.
@ast
A novel oral nutraceutical for ...... oof-of-concept clinical trial.
@en
P1433
P1476
P2093
P2860
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
A novel oral nutraceutical for ...... oof-of-concept clinical trial.
@en
P2093
P2860
P31
P356
10.1136/BMJOPEN-2012-002170
P433
P478
P577
P5875
P698
P921
P932